We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-15.62%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$163B
AUM Growth
+$35.8B
Cap. Flow
+$63.1B
Cap. Flow %
38.57%
Top 10 Hldgs %
39.01%
Holding
5,544
New
560
Increased
1,332
Reduced
2,502
Closed
413

Sector Composition

Rank Sector Weight
1 Technology 12.9%
2 Financials 7.33%
3 Healthcare 6.04%
4 Consumer Discretionary 5.46%
5 Communication Services 3.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDYA icon
4026
IDEAYA Biosciences
IDYA
$3.56B
$33K ﹤0.01%
2,364
-3,078
-57% -$34.2K
KZR
4027
DELISTED
Kezar Life Sciences
KZR
$33K ﹤0.01%
403
-212
-34% -$18.7K
TERN
4028
DELISTED
Terns Pharmaceuticals
TERN
$33K ﹤0.01%
13,125
-2,227
-15% -$4.45K
VXRT
4029
DELISTED
Vaxart
VXRT
$33K ﹤0.01%
9,281
-11,168
-55% -$41.7K
SQSP
4030
DELISTED
Squarespace, Inc.
SQSP
$33K ﹤0.01%
1,572
+1,166
+287% +$25K
SHAP.WS
4031
DELISTED
Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SHAP.WS
$33K ﹤0.01%
284,813
-314
-0.1% -$56
NOAC
4032
DELISTED
Natural Order Acquisition Corp. Common Stock
NOAC
$33K ﹤0.01%
+3,381
New +$33.3K
TMBR
4033
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$33K ﹤0.01%
2,072
+1,000
+93% +$14.6K
ABOS icon
4034
Acumen Pharmaceuticals
ABOS
$176M
$32K ﹤0.01%
6,724
-5,093
-43% -$19.1K
ACT icon
4035
Enact Holdings
ACT
$6.73B
$32K ﹤0.01%
1,507
-893
-37% -$20.4K
BTAI icon
4036
BioXcel Therapeutics
BTAI
$27.8M
$32K ﹤0.01%
152
-29
-16% -$6.1K
CRGY icon
4037
Crescent Energy
CRGY
$3.82B
$32K ﹤0.01%
2,630
-28,876
-92% -$481K
FPI
4038
Farmland Partners
FPI
$432M
$32K ﹤0.01%
2,298
-2,349
-51% -$34.2K
MVIS icon
4039
Microvision
MVIS
$78.9M
$32K ﹤0.01%
554
-1,276
-70% -$68.4K
PASG icon
4040
Passage Bio
PASG
$14.1M
$32K ﹤0.01%
678
-319
-32% -$14.9K
ROOT icon
4041
Root
ROOT
$798M
$32K ﹤0.01%
1,523
+261
+21% +$7.07K
SHYF
4042
DELISTED
The Shyft Group
SHYF
$32K ﹤0.01%
1,732
-4,288
-71% -$105K
STRL icon
4043
Sterling Infrastructure
STRL
$16.7B
$32K ﹤0.01%
1,470
-20,190
-93% -$485K
NESR
4044
National Energy Services Reunited Corp
NESR
$2.93B
$32K ﹤0.01%
4,649
-7,672
-62% -$55.8K
ESTE
4045
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$32K ﹤0.01%
2,291
-2,741
-54% -$43.1K
BLZE icon
4046
Backblaze
BLZE
$1.16B
$31K ﹤0.01%
5,845
BRY
4047
DELISTED
Berry Corp
BRY
$31K ﹤0.01%
4,023
-6,926
-63% -$73.2K
EWW icon
4048
iShares MSCI Mexico ETF
EWW
$1.99B
$31K ﹤0.01%
658
-39,693
-98% -$1.99M
ICVT icon
4049
iShares Convertible Bond ETF
ICVT
$7.35B
$31K ﹤0.01%
450
INZY
4050
DELISTED
Inozyme Pharma
INZY
$31K ﹤0.01%
6,403
-2,337
-27% -$10.2K

Similar funds

Barclays's Q2 2022 Portfolio in Review

As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.

  • Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
  • Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
  • Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
  • Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
  • Barclays opened 560 new positions and closed 413 in Q2 2022.
  • Barclays's portfolio value rose 28% quarter-over-quarter to $163B.

Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.